Table 1.
Variable | Number | Wnt7a (%) | P*-value | |
---|---|---|---|---|
Negative |
Positive | |||
Total | 70 | 44 (62.9) |
26 (37.1) | |
Age (years) | 0.927 | |||
≤60 | 22 | 14 (63.6) |
8 (36.4) | |
>60 | 48 | 30 (62.5) |
18 (37.5) | |
FIGO stage | 0.001 | |||
I+II | 39 | 18 (46.2) |
21 (53.8) | |
III+IV | 31 | 26 (83.9) |
5 (16.1) | |
Grade | 0.001 | |||
G1 | 30 | 12 (40.0) |
18 (60.0) | |
G2 + G3 | 40 | 32 (80.0) |
8 (20.0) | |
Lymph node metastasis | 0.002 | |||
Negative | 49 | 25 (51.0) |
24 (49.0) | |
Positive | 21 | 19 (90.5) |
2 (9.5) | |
Depth of myometrial invasion | 0.006 | |||
≤1/2 | 31 | 14 (45.2) |
17 (54.8) | |
>1/2 | 39 | 30 (76.9) |
9 (23.1) | |
LVS involvement | 0.001 | |||
Negative | 44 | 21 (47.7) |
23 (52.3) | |
Positive | 26 | 23 (88.5) |
3 (11.5) | |
Peritoneal cytology | 0.013 | |||
Negative | 53 | 29 (54.7) |
24 (45.3) | |
Positive | 17 | 15 (88.2) |
2 (11.8) |
FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space and *Chi-square test.